The title of this book pretty much sums up what will be found here: the history of total hip replacement (THR) in Europe (mainly Britain) and North America and an account of the interests of surgeons, manufacturers and patients. The volume\'s association with the Centre for the History of Science, Technology and Medicine at the University of Manchester delivers its promise, as the reader might expect, of high quality research and sound historical writing. Manchester was the obvious place from which such a work might appear since the most successful hip prosthesis was developed by a local surgeon, John Charnley, at Wrightington Hospital near Wigan. Here Charnley had a clinical unit and a workshop, and a practical, apprentice-trained engineer, Harry Craven. Charnley and Craven\'s prosthetic hip was, at first, a classic "string and sealing wax" development. Even when their design was taken up and produced commercially their chosen collaborator was Charles Thackray, the owner of a comparatively small surgical instrument making company of that name in nearby Leeds.

The success of Charnley\'s hip lay in its material base (the dual components of a high density polyethylene cup and a stainless steel femoral head); Charnley and Craven\'s dogged testing; Charnley\'s development of an operation with a very low risk of infection; and Charnley\'s control over the access surgeons had to the details of the prosthesis and its implantation. This part of the tale is quite well known but the authors flesh it out with archival detail. As might be expected, the book reveals that Charnley\'s narrative was not one of single-handed heroism. THR had a prehistory in the 1930s, and in the post-war years many groups in Europe and across the Atlantic were experimenting to produce artificial hips that could be implanted with safety and restored function for a long time. This story occupies most of the first half of the book whereas much of the second part is devoted to industrial dynamics: competition, patenting, marketing, innovation, etc. As such, this is where the United States figures large in the narrative. The authors do well to tell a complicated story for, as they recognize, commercialism cannot be treated *in vacuo* without reference to ageing populations and the costs and means of delivering health care. Finally patients and their expectations are explored although not as an afterthought but as part of the complex dynamics of modern, expensive, health services in different nations. Enriched by the new historiography of technology, this is a well-written piece of modern medical history. Well-written of course does not mean this is an "unputdownable" Arthur Conan Doyle short story. It is demanding and may be more often turned to for the parts rather than the whole.
